Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Comment by senatoriceon Jan 06, 2011 8:02am
169 Views
Post# 17931708

Annual Shareholder meeting Jan 25/11

Annual Shareholder meeting Jan 25/11

SIRONA BIOCHEM CORP.

Suite #950– 789 West Pender Street

Vancouver, British Columbia

V6C 1H2

Telephone: 604-641-4466

Facsimile: 604-568-7704

AMENDED NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF

SHAREHOLDERS

TO THE SHAREHOLDERS:

TAKE NOTICE that the 2010 Annual General and Special Meeting (the “Meeting”) of the

shareholders of Sirona Biochem Corp. (the “Company”) will be held at Suite 700, 595 Burrard Street,

Vancouver, British Columbia, V7X 1S8, is Tuesday, January 25, 2011 at 3:30 p. m. (Vancouver

time) and not Friday, January 25, 2011 as previously disclosed in the Notice and Information Circular

dated December 17, 2010.

The Information Circular previously delivered in connection with the Meeting remains valid.

DATED at Vancouver, British Columbia, this 31st day of December, 2010.

BY ORDER OF THE BOARD OF DIRECTORS

“Mark Senner”

Mark Senner

President and Director

Bullboard Posts